Cargando…
Impact of COVID-19 outbreak on regional STEMI care in Germany
AIMS: To assess the impact of the lockdown due to coronavirus disease 2019 (COVID-19) on key quality indicators for the treatment of ST-segment elevation myocardial infarction (STEMI) patients. METHODS: Data were obtained from 41 hospitals participating in the prospective Feedback Intervention and T...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364412/ https://www.ncbi.nlm.nih.gov/pubmed/32676681 http://dx.doi.org/10.1007/s00392-020-01703-z |
_version_ | 1783559826344771584 |
---|---|
author | Scholz, Karl Heinrich Lengenfelder, Björn Thilo, Christian Jeron, Andreas Stefanow, Stefan Janssens, Uwe Bauersachs, Johann Schulze, P. Christian Winter, Klaus Dieter Schröder, Jörg vom Dahl, Jürgen von Beckerath, Nicolas Seidl, Karlheinz Friede, Tim Meyer, Thomas |
author_facet | Scholz, Karl Heinrich Lengenfelder, Björn Thilo, Christian Jeron, Andreas Stefanow, Stefan Janssens, Uwe Bauersachs, Johann Schulze, P. Christian Winter, Klaus Dieter Schröder, Jörg vom Dahl, Jürgen von Beckerath, Nicolas Seidl, Karlheinz Friede, Tim Meyer, Thomas |
author_sort | Scholz, Karl Heinrich |
collection | PubMed |
description | AIMS: To assess the impact of the lockdown due to coronavirus disease 2019 (COVID-19) on key quality indicators for the treatment of ST-segment elevation myocardial infarction (STEMI) patients. METHODS: Data were obtained from 41 hospitals participating in the prospective Feedback Intervention and Treatment Times in ST-Elevation Myocardial Infarction (FITT-STEMI) study, including 15,800 patients treated for acute STEMI from January 2017 to the end of March 2020. RESULTS: There was a 12.6% decrease in the total number of STEMI patients treated at the peak of the pandemic in March 2020 as compared to the mean number treated in the March months of the preceding years. This was accompanied by a significant difference among the modes of admission to hospitals (p = 0.017) with a particular decline in intra-hospital infarctions and transfer patients from other hospitals, while the proportion of patients transported by emergency medical service (EMS) remained stable. In EMS-transported patients, predefined quality indicators, such as percentages of pre-hospital ECGs (both 97%, 95% CI = − 2.2–2.7, p = 0.846), direct transports from the scene to the catheterization laboratory bypassing the emergency department (68% vs. 66%, 95% CI = − 4.9–7.9, p = 0.641), and contact-to-balloon-times of less than or equal to 90 min (58.3% vs. 57.8%, 95%CI = − 6.2–7.2, p = 0.879) were not significantly altered during the COVID-19 crisis, as was in-hospital mortality (9.2% vs. 8.5%, 95% CI = − 3.2–4.5, p = 0.739). CONCLUSIONS: Clinically important indicators for STEMI management were unaffected at the peak of COVID-19, suggesting that the pre-existing logistic structure in the regional STEMI networks preserved high-quality standards even when challenged by a threatening pandemic. CLINICAL TRIAL REGISTRATION: NCT00794001 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00392-020-01703-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7364412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73644122020-07-16 Impact of COVID-19 outbreak on regional STEMI care in Germany Scholz, Karl Heinrich Lengenfelder, Björn Thilo, Christian Jeron, Andreas Stefanow, Stefan Janssens, Uwe Bauersachs, Johann Schulze, P. Christian Winter, Klaus Dieter Schröder, Jörg vom Dahl, Jürgen von Beckerath, Nicolas Seidl, Karlheinz Friede, Tim Meyer, Thomas Clin Res Cardiol Original Paper AIMS: To assess the impact of the lockdown due to coronavirus disease 2019 (COVID-19) on key quality indicators for the treatment of ST-segment elevation myocardial infarction (STEMI) patients. METHODS: Data were obtained from 41 hospitals participating in the prospective Feedback Intervention and Treatment Times in ST-Elevation Myocardial Infarction (FITT-STEMI) study, including 15,800 patients treated for acute STEMI from January 2017 to the end of March 2020. RESULTS: There was a 12.6% decrease in the total number of STEMI patients treated at the peak of the pandemic in March 2020 as compared to the mean number treated in the March months of the preceding years. This was accompanied by a significant difference among the modes of admission to hospitals (p = 0.017) with a particular decline in intra-hospital infarctions and transfer patients from other hospitals, while the proportion of patients transported by emergency medical service (EMS) remained stable. In EMS-transported patients, predefined quality indicators, such as percentages of pre-hospital ECGs (both 97%, 95% CI = − 2.2–2.7, p = 0.846), direct transports from the scene to the catheterization laboratory bypassing the emergency department (68% vs. 66%, 95% CI = − 4.9–7.9, p = 0.641), and contact-to-balloon-times of less than or equal to 90 min (58.3% vs. 57.8%, 95%CI = − 6.2–7.2, p = 0.879) were not significantly altered during the COVID-19 crisis, as was in-hospital mortality (9.2% vs. 8.5%, 95% CI = − 3.2–4.5, p = 0.739). CONCLUSIONS: Clinically important indicators for STEMI management were unaffected at the peak of COVID-19, suggesting that the pre-existing logistic structure in the regional STEMI networks preserved high-quality standards even when challenged by a threatening pandemic. CLINICAL TRIAL REGISTRATION: NCT00794001 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00392-020-01703-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-07-16 2020 /pmc/articles/PMC7364412/ /pubmed/32676681 http://dx.doi.org/10.1007/s00392-020-01703-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Scholz, Karl Heinrich Lengenfelder, Björn Thilo, Christian Jeron, Andreas Stefanow, Stefan Janssens, Uwe Bauersachs, Johann Schulze, P. Christian Winter, Klaus Dieter Schröder, Jörg vom Dahl, Jürgen von Beckerath, Nicolas Seidl, Karlheinz Friede, Tim Meyer, Thomas Impact of COVID-19 outbreak on regional STEMI care in Germany |
title | Impact of COVID-19 outbreak on regional STEMI care in Germany |
title_full | Impact of COVID-19 outbreak on regional STEMI care in Germany |
title_fullStr | Impact of COVID-19 outbreak on regional STEMI care in Germany |
title_full_unstemmed | Impact of COVID-19 outbreak on regional STEMI care in Germany |
title_short | Impact of COVID-19 outbreak on regional STEMI care in Germany |
title_sort | impact of covid-19 outbreak on regional stemi care in germany |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364412/ https://www.ncbi.nlm.nih.gov/pubmed/32676681 http://dx.doi.org/10.1007/s00392-020-01703-z |
work_keys_str_mv | AT scholzkarlheinrich impactofcovid19outbreakonregionalstemicareingermany AT lengenfelderbjorn impactofcovid19outbreakonregionalstemicareingermany AT thilochristian impactofcovid19outbreakonregionalstemicareingermany AT jeronandreas impactofcovid19outbreakonregionalstemicareingermany AT stefanowstefan impactofcovid19outbreakonregionalstemicareingermany AT janssensuwe impactofcovid19outbreakonregionalstemicareingermany AT bauersachsjohann impactofcovid19outbreakonregionalstemicareingermany AT schulzepchristian impactofcovid19outbreakonregionalstemicareingermany AT winterklausdieter impactofcovid19outbreakonregionalstemicareingermany AT schroderjorg impactofcovid19outbreakonregionalstemicareingermany AT vomdahljurgen impactofcovid19outbreakonregionalstemicareingermany AT vonbeckerathnicolas impactofcovid19outbreakonregionalstemicareingermany AT seidlkarlheinz impactofcovid19outbreakonregionalstemicareingermany AT friedetim impactofcovid19outbreakonregionalstemicareingermany AT meyerthomas impactofcovid19outbreakonregionalstemicareingermany |